CCR Milestones: Annual Highlights 2017

Every year, the Center for Cancer Research (CCR) makes remarkable contributions to the understanding, detection, treatment and prevention of cancer.

Improved imaging reveals protein structure in amazing detail, opening a path for accelerated drug development.

Understanding the immune response to tumors suggests that dietary changes may influence antitumor immunity.

Activated hormone receptors and other gene regulators help one another find new gene targets in breast cancer cells.

Communities of microbes that make their homes in the diverse environments on human skin can persist for years.

The discovery of a gene-activating enzyme’s role in reshaping DNA while it works suggests a new strategy for drug development.

A comprehensive molecular analysis of the second-most-common type of kidney cancer sets the stage for more precise diagnoses and more tailored treatments.

The identification of a cellular pathway involved in a rare premature aging syndrome suggests a strategy for treating the disorder and offers insight into the normal aging process.

Cancer cells find ways to survive damage they cannot fix.

Studies of some of the body’s simplest chemical components suggest new strategies for empowering the immune system.

A newly revealed target for a protein that drives cancer growth may lead to better treatment options.

Proteasomes use a previously unknown method to recognize and process proteins that need to be destroyed.

The capture of a molecular arrangement that exists for a fraction of a second may improve drug design.

A new imaging method enables sensitive detection and monitoring of high-risk prostate cancers.

Welcoming new faculty to CCR.

Awards and honors earned by CCR staff.